As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  5/9/24  Bristol-Myers Squibb Co.          8-K:5,9      5/7/24   12:255K                                   Broadridge Fin’l So… Inc 
  5/3/24  Lenkowsky Adam                    4          Officer²    1:7K   Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
 4/25/24  Bristol-Myers Squibb Co.          10-Q        3/31/24  106:11M                                                             
 4/25/24  Bristol-Myers Squibb Co.          8-K:2,7,9   4/25/24   13:3.6M                                                            
 4/22/24  Bristol-Myers Squibb Co.          DEFA14A                1:3.7M                                   Broadridge Fin’l So… Inc 
  4/2/24  Shanahan Karin                    4          Officer²    1:7K   Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
  4/2/24  Yale Phyllis R                    4          Director²   1:5K   Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
  4/2/24  Storch Gerald L                   4          Director²   1:5K   Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
  4/2/24  Samuels Theodore R. II            4          Director²   1:5K   Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
  4/2/24  Rice Derica W                     4          Director²   1:5K   Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
  4/2/24  Bhatt Deepak                      4          Director²   1:5K   Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
  4/2/24  Arduini Peter J                   4          Director²   1:5K   Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
 3/28/24  Bristol-Myers Squibb Co.          ARS        12/31/23    1:51M                                    Broadridge Fin’l So… Inc 
 3/28/24  Bristol-Myers Squibb Co.          DEFA14A                1:10M                                    Broadridge Fin’l So… Inc 
 3/28/24  Bristol-Myers Squibb Co.          DEF 14A      5/7/24   11:25M                                    Broadridge Fin’l So… Inc 
 3/18/24‡ Bristol-Myers Squibb Co.          8-K:5       3/13/24   11:202K                                   Broadridge Fin’l So… Inc 
 3/18/24  Bristol-Myers Squibb Co.          PRE 14A      5/7/24   12:25M                                    Broadridge Fin’l So… Inc 
 3/18/24  Bristol-Myers Squibb Co.          8-K:8,9     3/18/24   12:239K                                   Broadridge Fin’l So… Inc 
 3/12/24  Lenkowsky Adam                    4          Officer²    1:24K  Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
 3/12/24  Leung Sandra                      4          Officer²    1:24K  Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-Q	Quarterly Report — Form 10-Q.
	ARS	Annual Report to Security Holders.
	DEF 14A	Definitive Proxy Statement — Schedule 14A.
	DEFA14A	Definitive Additional Proxy Soliciting Material — Schedule 14A.
	PRE 14A	Preliminary Proxy Statement — Schedule 14A.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.